ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
GA09
|
551 |
197K |
48 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
551
|
197K
|
48
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Suspension from Official Quotation
|
|
GA09
|
448 |
124K |
4 |
06/03/24 |
06/03/24 |
ASX - By Stock
|
448
|
124K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
AKP Remedy
|
|
GA09
|
11 |
5.0K |
4 |
05/03/24 |
05/03/24 |
ASX - By Stock
|
11
|
5.0K
|
4
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
GA09
|
77 |
36K |
5 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
77
|
36K
|
5
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
GA09
|
77 |
36K |
13 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
77
|
36K
|
13
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Change of Director's Interest Notice - PH
|
|
GA09
|
77 |
36K |
11 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
77
|
36K
|
11
|
|
ASX - By Stock
|
IMU |
Re:
Ann: Imugene and NeoImmuneTech to Improve Cancer Treatments
|
|
GA09
|
96 |
45K |
8 |
12/12/23 |
12/12/23 |
ASX - By Stock
|
96
|
45K
|
8
|
|
ASX - By Stock
|
ASB |
Re:
News: ASB Austal Seeks Trading Halt
|
|
GA09
|
8 |
2.3K |
5 |
23/11/23 |
23/11/23 |
ASX - By Stock
|
8
|
2.3K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
GA09
|
1.0K |
389K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Update on BLA for Graft Versus Host Disease
|
|
GA09
|
1.0K |
389K |
0 |
04/08/23 |
04/08/23 |
ASX - By Stock
|
1.0K
|
389K
|
0
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
93 |
21K |
10 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
93
|
21K
|
10
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
93 |
21K |
4 |
28/10/22 |
28/10/22 |
ASX - By Stock
|
93
|
21K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Trading Halt
|
|
GA09
|
43 |
15K |
3 |
22/08/22 |
22/08/22 |
ASX - By Stock
|
43
|
15K
|
3
|
|
ASX - By Stock
|
KNO |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
10 |
6.3K |
3 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
10
|
6.3K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Quarterly update not posted this morning ?
|
|
GA09
|
25 |
6.1K |
1 |
29/07/22 |
29/07/22 |
ASX - By Stock
|
25
|
6.1K
|
1
|
|
ASX - By Stock
|
AUZ |
Re:
Analysis only please
|
|
GA09
|
176 |
48K |
10 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
176
|
48K
|
10
|
|
ASX - By Stock
|
AUZ |
Re:
Analysis only please
|
|
GA09
|
176 |
48K |
5 |
13/05/22 |
13/05/22 |
ASX - By Stock
|
176
|
48K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Director Appointment
|
|
GA09
|
213 |
58K |
15 |
24/03/22 |
24/03/22 |
ASX - By Stock
|
213
|
58K
|
15
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Preliminary Final Report
|
|
GA09
|
111 |
30K |
0 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
111
|
30K
|
0
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Preliminary Final Report
|
|
GA09
|
111 |
30K |
2 |
01/03/22 |
01/03/22 |
ASX - By Stock
|
111
|
30K
|
2
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Change of Director's Interest Notice x 4
|
|
GA09
|
17 |
6.8K |
14 |
11/01/22 |
11/01/22 |
ASX - By Stock
|
17
|
6.8K
|
14
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Fabrication Agreement with Earth Mountain
|
|
GA09
|
805 |
235K |
2 |
08/01/22 |
08/01/22 |
ASX - By Stock
|
805
|
235K
|
2
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Consolidation/Split - AUZ
|
|
GA09
|
135 |
57K |
7 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
135
|
57K
|
7
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Consolidation/Split - AUZ
|
|
GA09
|
135 |
57K |
3 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
135
|
57K
|
3
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Consolidation/Split - AUZ
|
|
GA09
|
135 |
57K |
7 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
135
|
57K
|
7
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Consolidation/Split - AUZ
|
|
GA09
|
135 |
57K |
0 |
22/12/21 |
22/12/21 |
ASX - By Stock
|
135
|
57K
|
0
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Consolidation/Split - AUZ
|
|
GA09
|
135 |
57K |
10 |
21/12/21 |
21/12/21 |
ASX - By Stock
|
135
|
57K
|
10
|
|
ASX - By Stock
|
AKP |
Re:
Whats the chance?
|
|
GA09
|
494 |
121K |
7 |
15/12/21 |
15/12/21 |
ASX - By Stock
|
494
|
121K
|
7
|
|
ASX - By Stock
|
MSB |
Re:
OTAT Meeting
|
|
GA09
|
36 |
9.5K |
1 |
14/12/21 |
14/12/21 |
ASX - By Stock
|
36
|
9.5K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Whats the chance?
|
|
GA09
|
494 |
121K |
2 |
02/12/21 |
02/12/21 |
ASX - By Stock
|
494
|
121K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB and Oaktree Conclude Refinancing of Senior Debt Facility
|
|
GA09
|
451 |
113K |
16 |
22/11/21 |
22/11/21 |
ASX - By Stock
|
451
|
113K
|
16
|
|
ASX - By Stock
|
AKP |
Re:
Whats the chance?
|
|
GA09
|
494 |
121K |
1 |
09/11/21 |
09/11/21 |
ASX - By Stock
|
494
|
121K
|
1
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
182 |
43K |
0 |
29/10/21 |
29/10/21 |
ASX - By Stock
|
182
|
43K
|
0
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
GA09
|
17K |
6.6M |
1 |
19/09/21 |
19/09/21 |
ASX - By Stock
|
17K
|
6.6M
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
GA09
|
206 |
62K |
5 |
31/08/21 |
31/08/21 |
ASX - By Stock
|
206
|
62K
|
5
|
|
ASX - By Stock
|
AKP |
Re:
Why are the directors not capitalising on this moment!?
|
|
GA09
|
146 |
43K |
6 |
29/08/21 |
29/08/21 |
ASX - By Stock
|
146
|
43K
|
6
|
|
ASX - By Stock
|
AKP |
Re:
Why are the directors not capitalising on this moment!?
|
|
GA09
|
146 |
43K |
6 |
28/08/21 |
28/08/21 |
ASX - By Stock
|
146
|
43K
|
6
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Market Update - Progress Report
|
|
GA09
|
364 |
124K |
3 |
26/08/21 |
26/08/21 |
ASX - By Stock
|
364
|
124K
|
3
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
63 |
22K |
2 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
63
|
22K
|
2
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
63 |
22K |
7 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
63
|
22K
|
7
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
GA09
|
63 |
22K |
7 |
29/07/21 |
29/07/21 |
ASX - By Stock
|
63
|
22K
|
7
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Market Update - Progress Report
|
|
GA09
|
272 |
85K |
19 |
28/07/21 |
28/07/21 |
ASX - By Stock
|
272
|
85K
|
19
|
|
ASX - By Stock
|
AUZ |
Re:
Ann: Trading Halt
|
|
GA09
|
75 |
29K |
4 |
27/07/21 |
27/07/21 |
ASX - By Stock
|
75
|
29K
|
4
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Market Update - Progress Report
|
|
GA09
|
210 |
64K |
7 |
15/07/21 |
15/07/21 |
ASX - By Stock
|
210
|
64K
|
7
|
|
ASX - By Stock
|
FGR |
Re:
Ann: FGR Appoints Managing Director
|
|
GA09
|
6 |
2.8K |
3 |
05/07/21 |
05/07/21 |
ASX - By Stock
|
6
|
2.8K
|
3
|
|
ASX - By Stock
|
FGR |
Re:
Ann: FGR Distribution Agreement with GtM Action
|
|
GA09
|
35 |
11K |
4 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
35
|
11K
|
4
|
|
ASX - By Stock
|
FGR |
Re:
Ann: FGR Distribution Agreement with GtM Action
|
|
GA09
|
35 |
11K |
6 |
02/07/21 |
02/07/21 |
ASX - By Stock
|
35
|
11K
|
6
|
|
ASX - By Stock
|
AKP |
Re:
Ann: Results of Meeting
|
|
GA09
|
67 |
27K |
2 |
17/06/21 |
17/06/21 |
ASX - By Stock
|
67
|
27K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Alzheimer drug approved
|
|
GA09
|
243 |
73K |
6 |
08/06/21 |
08/06/21 |
ASX - By Stock
|
243
|
73K
|
6
|
|
ASX - By Stock
|
AKP |
Re:
Israel is Open
|
|
GA09
|
21 |
9.1K |
0 |
14/05/21 |
14/05/21 |
ASX - By Stock
|
21
|
9.1K
|
0
|
|